-
1
-
-
67650755016
-
Safety and efficacy of drug-eluting and bare-metal stents: Comprehensive meta-analysis of randomized trials and observational studies
-
Kirtane AJ, Gupta A, Iyengar S, et al. Safety and efficacy of drug-eluting and bare-metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009;119:3198-3206
-
(2009)
Circulation
, vol.119
, pp. 3198-3206
-
-
Kirtane, A.J.1
Gupta, A.2
Iyengar, S.3
-
2
-
-
58149265063
-
Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: Does stent diameter matter? Three-year follow-up of BASKET
-
Pfisterer M, Brunner-La Rocca HP, Rickenbacher P, et al. Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET. Eur Heart J 2009;30:16-24.
-
(2009)
Eur Heart J
, vol.30
, pp. 16-24
-
-
Pfisterer, M.1
Brunner-La Rocca, H.P.2
Rickenbacher, P.3
-
3
-
-
51649119808
-
Incidence and correlates of drug-eluting stents in routine clinical practice: 4-year results from a large 2-institutional cohort study
-
Wenaweser P, Daemen J, Zwahlen M, et al. Incidence and correlates of drug-eluting stents in routine clinical practice: 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol 2008;52:1134-1140
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 1134-1140
-
-
Wenaweser, P.1
Daemen, J.2
Zwahlen, M.3
-
4
-
-
77951001904
-
Duration of dual anti-platelet therapy after implantation of drug-eluting stents
-
Park S-J, Park D-W, Kim Y-H, et al. Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med 2010;362:1374-1382
-
(2010)
N Engl J Med
, vol.362
, pp. 1374-1382
-
-
Park, S.-J.1
Park, D.-W.2
Kim, Y.-H.3
-
5
-
-
0037145863
-
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial
-
Erratum, JAMA 2003;289:987
-
Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-2420 [Erratum, JAMA 2003;289:987.]
-
(2002)
JAMA
, vol.288
, pp. 2411-2420
-
-
Steinhubl, S.R.1
Berger, P.B.2
Mann III, J.T.3
-
6
-
-
33846413580
-
Long-Term Versus Short-Term Clopidogrel Therapy in Patients Undergoing Coronary Stenting (from the Randomized Argentine Clopidogrel Stent [RACS] Trial)
-
DOI 10.1016/j.amjcard.2006.08.034, PII S0002914906020595
-
Bernardi V, Szarfer J, Summay G, et al. Long-term versus short-term clopidogrel therapy in patients undergoing coronary stenting (from the Randomized Argentine Clopidogrel Stent [RACS] trial). Am J Cardiol 2007;99:349-352 (Pubitemid 46149552)
-
(2007)
American Journal of Cardiology
, vol.99
, Issue.3
, pp. 349-352
-
-
Bernardi, V.1
Szarfer, J.2
Summay, G.3
Mendiz, O.4
Sarmiento, R.5
Alemparte, M.R.6
Gabay, J.7
Berger, P.B.8
-
7
-
-
33645861080
-
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
-
Bhatt DL, Fox KAA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-1717
-
(2006)
N Engl J Med
, vol.354
, pp. 1706-1717
-
-
Bhatt, D.L.1
Fox, K.A.A.2
Hacke, W.3
-
8
-
-
17844373254
-
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
-
Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130
-
(2005)
JAMA
, vol.293
, pp. 2126-2130
-
-
Iakovou, I.1
Schmidt, T.2
Bonizzoni, E.3
-
9
-
-
64049096437
-
Predictors of coronary stent thrombosis: The Dutch Stent Thrombosis Registry
-
van Werkum JW, Heestermans AA, Zomer AC, et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol 2009;53:1399-1409
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 1399-1409
-
-
Van Werkum, J.W.1
Heestermans, A.A.2
Zomer, A.C.3
|